Júlio Teixeira, SA

What Júlio Teixeira, SA does

Júlio Teixeira, SA is a Portuguese radiotherapy services provider headquartered in Senhora da Hora, Porto, operating as a subsidiary-like entity within the Stingray Healthcare Group. The company delivers advanced radiation oncology treatments to oncology patients across Portugal, with direct clinical sites in Porto and Lisboa (located within Centro Clínico Mário Vilhena) and an embedded operational presence at Hospital de Braga. It employs 21 staff and has been operating for more than 30 years, serving patients referred from hospitals and physicians, as well as directly booked cases, with payment routed through health insurers, the Portuguese National Health Service (SNS), and out-of-pocket payments.

The company's core offering is a comprehensive radiotherapy portfolio spanning external beam radiotherapy, stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) via the Cyberknife M6, intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT/RapidArc), image-guided radiotherapy (IGRT), respiratory-gated radiotherapy, 3D conformal radiotherapy, and high-dose-rate brachytherapy. The technology base includes Cyberknife M6 (described as the latest stereotactic technology on the Iberian Peninsula), Varian TrueBeam and Trilogy linear accelerators, an Elekta Harmony Pro linear accelerator commissioned at Hospital de Braga in July 2026, a GE LightSpeed RT16 CT scanner for planning, a Varisource HDR brachytherapy system, and Eclipse/Helios/Iplan treatment planning software. The company is ISO 9001:2015 certified and complies with EURATOM radiation protection regulations.

Revenue is generated through fee-for-service oncology treatment delivery, with go-to-market executed via phone-based appointment booking, physician referral networks, and hospital partnerships. The company distinguishes itself on technology breadth, no-waiting-list access, and clinical expertise, and recently expanded its service surface through renewed PME Líder status (2024), the CITE Salary Equality Seal (2024), and a Best Poster Award at the ART 2025 National Congress for TrueBeam gating validation. The customer base is a mix of individual oncology patients and institutional partners (notably Hospital de Braga), with revenue concentration risk lying in the hospital partnership layer.

Name

Júlio Teixeira, SA

Legal name

Júlio Teixeira, S.A.

Website

https://julioteixeira.pt

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Júlio Teixeira, SA is a Portuguese radiation oncology services provider operating advanced linear accelerators (Cyberknife M6, Varian TrueBeam, Elekta Harmony Pro) from clinics in Porto and Lisboa, plus an embedded site at Hospital de Braga, serving oncology patients under insurance, SNS, and direct payment.

Ownership category

akta.pro rank

Product category

Radiation Oncology Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industry

Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

• Radiotherapy services
• Radiation oncology
• Stereotactic radiosurgery
• Cancer treatment
• Brachytherapy

Headquarters

HQ city

Porto

HQ country

Portugal

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D

Revenue model

1. Healthcare Service Provision: Júlio Teixeira generates revenue through the provision of radiotherapy and radiation oncology services to patients. Services are billed through health insurance plans, insurance companies, and directly to patients. The company provides treatments including external radiotherapy, stereotactic radiotherapy, radiosurgery, and brachytherapy.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Júlio Teixeira, SA provides radiation oncology and radiotherapy services to oncology patients from clinical facilities in Porto and Lisboa, plus an on-site service at Hospital de Braga. The company delivers external beam radiotherapy (3D-CRT, IMRT, VMAT/RapidArc, IGRT), stereotactic radiosurgery and stereotactic body radiotherapy using Cyberknife M6, and high-dose-rate brachytherapy, with personalized treatment plans defined by a radiation oncologist at the first consultation.

Product overview

Júlio Teixeira, SA is a radiation oncology/radiotherapy service provider operating as part of the Stingray Healthcare Group. The company offers a comprehensive portfolio of radiotherapy treatments and techniques, including SRS/SBRT stereotactic treatments using Cyberknife, RapidArc VMAT, IMRT, IGRT, 3D conformal radiotherapy, and HDR brachytherapy. The service portfolio is supported by advanced medical equipment including Cyberknife M6, Varian TrueBeam, Trilogy, and Elekta Harmony Pro linear accelerators, GE CT scanner, and treatment planning systems (Eclipse/Helios/Iplan). The company provides both conventional fractionated radiotherapy and stereotactic treatments in single or hypofractionated schedules, serving oncology patients primarily in Portugal.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapy Services (External Beam and Brachytherapy)
• SRS – Radiocirurgia (Cyberknife)
• SBRT – Stereotactic Body Radiotherapy
• RapidArc – Volumetric Modulated Arc Therapy

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature7 records

Partnerships

Six partnerships are on record, tiered major, core and minor.

• ElektamajorTechnology or Integration · 13 July 2026Elekta provides the Harmony Pro linear accelerator technology installed at Hospital de Braga, enabling advanced radiotherapy techniques including 3D-CRT, IMRT, and VMAT.
• Varian Medical SystemsmajorTechnology or Integration · 13 July 2026Varian provides TrueBeam and Trilogy linear accelerators for radiotherapy treatments. The company won Best Poster Award at ART 2025 for validation of gating system on TrueBeam for SBRT treatments.
• Stingray Healthcare GroupcoreStrategic or Co-development PartnerJúlio Teixeira is part of the Stingray Healthcare Group, which provides access to a European network of specialized oncology centers, promoting clinical knowledge sharing and adoption of new technologies. The group combines over 30 years of experience in radiotherapy in Portugal with European best practices.
• Hospital de BragacoreStrategic or Co-development PartnerJúlio Teixeira provides radiotherapy services at Hospital de Braga, operating advanced linear accelerators including the new Elekta Harmony Pro system. The partnership extends radiotherapy capabilities at the hospital.
• AstraZenecaminorGTM or Marketing PartnerDr. Paulo Costa participated in MDT Lung Talks organized by AstraZeneca, discussing advances in lung cancer treatment.
• MSDminorGTM or Marketing PartnerMSD promoted Lung Networks 3rd Edition where Dr. Paulo Costa participated discussing challenges in early-stage lung cancer treatment.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Affidea: European operator of diagnostic imaging, outpatient and cancer care centers including radiotherapy, with clinics in Portugal, Spain, Italy and CEE. Comparable as a multi-country ambulatory cancer-care provider combining imaging, radiotherapy and multi-specialty services.
• Grupo IMO (Instituto Madrileño de Oncología): Iberian specialist in radiation oncology operating multiple linear accelerators across Spain. Directly comparable as an Iberian Peninsula radiotherapy services provider with similar SRS/SBRT, IMRT and VMAT capabilities.
• GenesisCare: One of the largest private radiation oncology and cardiology operators globally, with a significant network of radiotherapy centers across Europe (including Iberia) and Australia. Directly comparable as a multi-linac, multi-modality external-beam radiotherapy provider serving oncology patients on a similar reimbursement-driven model.

Broad incumbents

• Accuray: Manufacturer of the Cyberknife system — including the M6 model installed at Júlio Teixeira. Comparable as a broad incumbent that defines the stereotactic radiosurgery category and whose technology roadmap shapes Júlio Teixeira's SRS/SBRT offering.
• Varian Medical Systems (Siemens Healthineers): Manufacturer of TrueBeam and Trilogy linear accelerators and the Eclipse treatment-planning system that Júlio Teixeira operates. Comparable as a broad incumbent in radiation oncology technology, defining the equipment platform on which Júlio Teixeira's services run.
• IBA (Ion Beam Applications): Belgian provider of proton therapy and other advanced radiotherapy systems. Comparable as a broad incumbent in next-generation irradiation equipment, relevant to Júlio Teixeira's positioning on technology adoption and competitive context.
• Elekta: Manufacturer of the Harmony Pro linear accelerator now in clinical operation at Hospital de Braga. Comparable as a broad incumbent supplying the linac hardware and software ecosystem that underpins Júlio Teixeira's radiotherapy delivery.

Regional players

• Medipol Mega Hospital Complex: Large Turkish private hospital and oncology center with advanced radiotherapy capability. Comparable as a regional incumbent with multi-modality cancer care outside Iberia, illustrating the same private radiotherapy operating model in a different geography.
• Grupo Trofa Saúde: Portuguese private hospital and outpatient group providing oncology services domestically. Comparable as a regional player operating in the same Portuguese market and competing for oncology referral flows.
• Luz Saúde: Largest private healthcare group in Portugal, operating hospitals and outpatient services including oncology. Comparable as a regional incumbent shaping the competitive landscape for oncology referrals and radiotherapy demand in Portugal.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/j%C3%BAlio-teixeira-sa

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Júlio Teixeira, SA